{
    "2018-04-20": [
        [
            {
                "time": "",
                "original_text": "[买入评级]泰格医药(300347)年报点评：BE试验+创新药临床 公司业绩持续高速增长",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "BE试验",
                        "创新药",
                        "临床",
                        "业绩",
                        "高速增长"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "[买入-A评级]泰格医药(300347)年报点评：CRO行业高景气 收入和净利润高速增长",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "CRO行业",
                        "高景气",
                        "收入",
                        "净利润",
                        "高速增长"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "[推荐评级]泰格医药(300347)年报点评：业绩符合预期 受益创新药发展趋势",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "业绩",
                        "符合预期",
                        "创新药",
                        "发展趋势"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}